Home > Financial Ratios > GLAND PHARMA

GLAND PHARMA
EBIT Growth

    Back to All Ratios
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) -34.6021.3433.82-

What is the latest EBIT Growth ratio of GLAND PHARMA ?

The latest EBIT Growth ratio of GLAND PHARMA is -34.60 based on Mar2023 Consolidated results.
Year EBIT Growth
Mar2023-34.60
Mar202221.34
Mar202133.82
Mar2020-

How is EBIT Growth of GLAND PHARMA Trending?

Years EBIT Growth % Change
Mar2023 -34.6
Negative
Mar2022 21.34
-36.90
Mar2021 33.82
0
Mar2020 0 -

Other Financial Ratios of GLAND PHARMA


Compare EBIT Growth ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹27,732.2 Cr -2.6% -7.3% 26.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹361,916.0 Cr 0.3% -7.5% 53.9% Stock Analytics
CIPLA ₹115,034.0 Cr 1.1% -4.8% 56.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,929.0 Cr 1.6% 1.6% 27.6% Stock Analytics
DIVIS LABORATORIES ₹104,873.0 Cr -1.9% 10.7% 21.4% Stock Analytics
ZYDUS LIFESCIENCES ₹100,322.0 Cr 5.2% -0.2% 90.1% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-2.6%

-7.3%

26.7%

SENSEX

-0.6%

0.3%

21.8%


You may also like the below Video Courses